A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Partial Onset SeizuresEpilepsy
Interventions
DRUG

Perampanel

Perampanel tablets.

Trial Locations (12)

226014

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow

400012

Seth G S Medical College & KEM Hospital, Mumbai

411004

Deenanath Mangeshkar Hospital and Research Centre, Pune

411057

Lifepoint Multispecialty Hospital, Pune

440012

Brain Clinic, Jasleen Hospital, Nagpur

Getwell Hospital and Research Institute, Nagpur

500082

Nizam's Institute of Medical Sciences Department of Neurology, Hyderabad

560060

BGS Gleneagles Global Hospitals, Bengaluru

700026

Ramakrishna mission seva pratisthan vivekananda institute of medical sciences, Kolkata

700068

Sri Aurobindo Seva Kendra, Kolkata

Unknown

Shri Ganga Ram Hospital, Delhi

Advance Neurology & Superspeciality Hospital, Jaipur

All Listed Sponsors
lead

Eisai Pharmaceuticals India Pvt. Ltd

INDUSTRY

NCT03836924 - A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older | Biotech Hunter | Biotech Hunter